320 related articles for article (PubMed ID: 19661345)
1. Prognostic impact of CD68 and kallikrein 6 in human glioma.
Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
[TBL] [Abstract][Full Text] [Related]
2. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis.
Hasselblom S; Hansson U; Sigurdardottir M; Nilsson-Ehle H; Ridell B; Andersson PO
Pathol Int; 2008 Aug; 58(8):529-32. PubMed ID: 18705775
[TBL] [Abstract][Full Text] [Related]
6. Ezrin expression in tissue microarray of primary and recurrent gliomas.
Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.
Strojnik T; Kos J; Zidanik B; Golouh R; Lah T
Clin Cancer Res; 1999 Mar; 5(3):559-67. PubMed ID: 10100707
[TBL] [Abstract][Full Text] [Related]
9. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas.
Varela M; Ranuncolo SM; Morand A; Lastiri J; De Kier Joffé EB; Puricelli LI; Pallotta MG
J Surg Oncol; 2004 Apr; 86(1):34-40. PubMed ID: 15048678
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.
Liu C; Tian G; Tu Y; Fu J; Lan C; Wu N
Jpn J Clin Oncol; 2009 Oct; 39(10):625-31. PubMed ID: 19797419
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
13. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas.
Brell M; Ibáñez J; Felpete A; Burguera B; Frontera M; Couce ME
Brain Tumor Pathol; 2011 Apr; 28(2):137-44. PubMed ID: 21331614
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
16. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
18. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of macrophage infiltration in leiomyosarcomas.
Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
